RHYTHM Biosciences Ltd (RHY) - Total Liabilities

Latest as of December 2025: AU$955.41K AUD ≈ $676.01K USD

Based on the latest financial reports, RHYTHM Biosciences Ltd (RHY) has total liabilities worth AU$955.41K AUD (≈ $676.01K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

RHYTHM Biosciences Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how RHYTHM Biosciences Ltd's total liabilities have evolved over time, based on quarterly financial data. See RHYTHM Biosciences Ltd (RHY) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

RHYTHM Biosciences Ltd Competitors by Total Liabilities

The table below lists competitors of RHYTHM Biosciences Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Blue Star Helium Ltd AU:BNL	Australia	AU$32.72 Million
Sanatana Resources V:STA	Canada	CA$1.12 Million
Dataproces Group A/S CO:DATA	Denmark	Dkr37.94 Million
DL Holdings Co Ltd Preferred KO:000215	Korea	₩7.26 Trillion
Emdeki Utama Tbk PT JK:MDKI	Indonesia	Rp73.09 Billion
Indah Prakasa Sentosa PT Tbk JK:INPS	Indonesia	Rp283.96 Billion
United Homes Group Inc. NASDAQ:UHG	USA	$219.26 Million
Investors House HE:INVEST	Finland	€20.00 Million

Liability Composition Analysis (2017–2025)

This chart breaks down RHYTHM Biosciences Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of RHYTHM Biosciences Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.31	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.45	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how RHYTHM Biosciences Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for RHYTHM Biosciences Ltd (2017–2025)

The table below shows the annual total liabilities of RHYTHM Biosciences Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$2.17 Million ≈ $1.54 Million	+233.34%
2024-06-30	AU$651.54K ≈ $461.01K	-64.22%
2023-06-30	AU$1.82 Million ≈ $1.29 Million	+70.87%
2022-06-30	AU$1.07 Million ≈ $754.06K	-21.81%
2021-06-30	AU$1.36 Million ≈ $964.39K	+69.77%
2020-06-30	AU$802.85K ≈ $568.07K	+111.44%
2019-06-30	AU$379.71K ≈ $268.67K	+157.64%
2018-06-30	AU$147.38K ≈ $104.28K	+16.52%
2017-06-30	AU$126.48K ≈ $89.49K	--

About RHYTHM Biosciences Ltd

AU:RHY Australia Diagnostics & Research

Market Cap

$26.69 Million

AU$37.72 Million AUD

Market Cap Rank

#24196 Global

#968 in Australia

Share Price

AU$0.12

Change (1 day)

+0.00%

52-Week Range

AU$0.05 - AU$0.26

All Time High

AU$2.00